date/time interval
- September 1, 2022 - January 7, 2024
Targeting cysteine susceptibility in glioblastoma
Grant
Overview
awarded by
administered by
sponsor award ID
- 1 K08 NS128263-01
Affiliation
contributor
- Blenis, John Key Personnel 2022 - 2023
- Fink, Matthew E. Key Personnel 2022 - 2023